Your browser doesn't support javascript.
loading
Long-term health-related quality-of-life and symptom response profiles with arformoterol in COPD: results from a 52-week trial.
Donohue, James F; Bollu, Vamsi K; Stull, Donald E; Nelson, Lauren M; Williams, Valerie Sl; Stensland, Michael D; Hanania, Nicola A.
Afiliação
  • Donohue JF; Department of Pulmonary Diseases and Critical Care Medicine, The University of North Carolina at Chapel Hill, Chapel Hill, NC.
  • Bollu VK; Worldwide Health Economics and Outcomes Research, Bristol-Myers Squibb, Princeton, NJ.
  • Stull DE; Data Analytics and Design Strategy.
  • Nelson LM; Psychometrics, RTI Health Solutions, Research Triangle Park, NC.
  • Williams VS; Psychometrics, RTI Health Solutions, Research Triangle Park, NC.
  • Stensland MD; Agile Outcomes Research, Inc., Rochester, MN.
  • Hanania NA; Section of Pulmonary and Critical Care Medicine, Baylor College of Medicine, Houston, TX, USA.
Int J Chron Obstruct Pulmon Dis ; 13: 499-508, 2018.
Article em En | MEDLINE | ID: mdl-29440887
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Qualidade de Vida / Broncodilatadores / Doença Pulmonar Obstrutiva Crônica / Agonistas de Receptores Adrenérgicos beta 2 / Fumarato de Formoterol / Pulmão Idioma: En Ano de publicação: 2018 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Qualidade de Vida / Broncodilatadores / Doença Pulmonar Obstrutiva Crônica / Agonistas de Receptores Adrenérgicos beta 2 / Fumarato de Formoterol / Pulmão Idioma: En Ano de publicação: 2018 Tipo de documento: Article